Search results
Jonathan Fassberg is a visionary entrepreneur who founded astr partners, a financial services firm, and wrote Simple Acts, a book on giving back. He has a background in finance, Jewish studies, and tennis, and is involved in various organizations and causes.
Mar 22, 2021 · The Healthcare Investment Banking team has added Jonathan Fassberg in the newly created role of Vice Chairman, Brian Korb as Managing Director, and Don Ritucci as Managing Director and Head of Healthcare Mergers and Acquisitions (“M&A”).
Jonathan Fassberg is a vice chairman of healthcare investment banking at Oppenheimer & Co. and a co-CEO of Solebury Trout. He also invested in Cellevolve Bio, a biotech startup, in 2021.
Mar 23, 2021 · Oppenheimer, a leading investment bank, announced the hiring of Jonathan Fassberg as Vice Chairman of Healthcare Investment Banking. He will leverage his experience and contacts in biotech and life sciences to enhance Oppenheimer's presence in the sector.
Mar 22, 2021 · Fassberg brings 30 years of experience in healthcare investment banking and M&A to Oppenheimer, where he will lead the firm's Healthcare Investment Banking group. He will work with Brian Korb, who also joins as Managing Director, and Don Ritucci, who is appointed Head of M&A for Healthcare.
Mar 24, 2021 · Oppenheimer (NYSE:OPY) continued to build out its healthcare leadership team, adding three members to its healthcare investment banking team: Jonathan Fassberg, in the newly created role of vice chairman; Brian Korb, as a managing director; and Don Ritucci, as a managing director and head of healthcare M&A.
Jonathan Fassberg recognized early in his career that small-cap biotechnology companies were underserved in an investor relations capacity. To fill this void, Jonathan founded The Trout Group in 1996 and grew it to become the leading investor relations firm in the life sciences industry.
